55 results
6-K
EX-99.1
GNFT
Genfit
25 Apr 24
Current report (foreign)
4:10pm
impact of its activity, and its low environmental footprint, could create meaningful long-term value for patients, healthcare systems, employees … and shareholders, and assure the Company’s growth and long- term future.
ABOUT GENFIT
GENFIT is a late-stage biopharmaceutical company committed
6-K
EX-99.1
vzzxqc
8 Dec 23
Current report (foreign)
8:00am
6-K
EX-99.1
qapo08 cxu56w45g
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
6-K
EX-99.1
ey2tj gip8m95lsbw
6 Dec 23
Current report (foreign)
11:30am
6-K
EX-99.1
dhpbcg9
13 Nov 23
Current report (foreign)
4:30pm
6-K
EX-99.1
fnbkrhi3jje0g
20 Sep 23
Current report (foreign)
4:44pm
6-K
EX-99.1
93v0dfswzo os
30 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.1
o7i a85q16ou74c1
28 Apr 23
GENFIT Announces Publication of Extra-Financial Performance Report 2022
6:00am
F-3
l7f3k
18 Apr 23
Shelf registration (foreign)
2:33pm
6-K
EX-99.2
iri7wcvl
28 Sep 22
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
EX-99.1
pu4st00w3i i34
25 May 22
Current report (foreign)
4:10pm
6-K
EX-99.1
b2ey9aormuege1vbe3
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm